Evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for hormone receptor–positive metastatic breast cancer: a pooled analysis from the LEA (GEICAM/2006-11_GBG51) and CALGB 40503 (Alliance) trials
Martín, M., Loibl, S., Hyslop, T., De la Haba-Rodríguez, J., Aktas, B., Cirrincione, C.T., Mehta, K., Barry, W.T., Morales, S., Carey, L.A., Garcia-Saenz, J.A., Partridge, A., Martinez-Jañez, N., Hahn, O., Winer, E., Guerrero-Zotano, A., Hudis, C., Casas, M., Rodriguez-Martin, C., Furlanetto, J., Carrasco, E., Dickler, M.N.
Published in European journal of cancer (1990) (01.08.2019)
Published in European journal of cancer (1990) (01.08.2019)
Get full text
Journal Article
Neoadjuvant letrozole and palbociclib in patients with HR-positive/HER2-negative early breast cancer and Oncotype DX Recurrence Score ≥18: DxCARTES study
Guerrero-Zotano, Á., Pérez-García, J.M., Ruiz-Borrego, M., Bermejo, B., Gil-Gil, M., de la Haba, J., Alba Conejo, E., Quiroga, V., Carañana, V., Urruticoechea, A., Morales, S., Bellet, M., Antón, A., Fernández-Abad, M., Sánchez-Rovira, P., Calabuig, L., Pérez-Escuredo, J., Sampayo-Cordero, M., Cortés, J., Llombart-Cussac, A.
Published in ESMO open (01.10.2024)
Published in ESMO open (01.10.2024)
Get full text
Journal Article
Palbociclib in combination with endocrine therapy versus capecitabine in hormonal receptor-positive, human epidermal growth factor 2-negative, aromatase inhibitor-resistant metastatic breast cancer: a phase III randomised controlled trial—PEARL
Martin, M., Zielinski, C., Ruiz-Borrego, M., Carrasco, E., Turner, N., Ciruelos, E.M., Muñoz, M., Bermejo, B., Margeli, M., Anton, A., Kahan, Z., Csöszi, T., Casas, M.I., Murillo, L., Morales, S., Alba, E., Gal-Yam, E., Guerrero-Zotano, A., Calvo, L., de la Haba-Rodriguez, J., Ramos, M., Alvarez, I., Garcia-Palomo, A., Huang Bartlett, C., Koehler, M., Caballero, R., Corsaro, M., Huang, X., Garcia-Sáenz, J.A., Chacón, J.I., Swift, C., Thallinger, C., Gil-Gil, M.
Published in Annals of oncology (01.04.2021)
Published in Annals of oncology (01.04.2021)
Get full text
Journal Article
Neratinib + fulvestrant + trastuzumab for HR-positive, HER2-negative, HER2-mutant metastatic breast cancer: outcomes and biomarker analysis from the SUMMIT trial
Jhaveri, K., Eli, L.D., Wildiers, H., Hurvitz, S.A., Guerrero-Zotano, A., Unni, N., Brufsky, A., Park, H., Waisman, J., Yang, E.S., Spanggaard, I., Reid, S., Burkard, M.E., Vinayak, S., Prat, A., Arnedos, M., Bidard, F.-C., Loi, S., Crown, J., Bhave, M., Piha-Paul, S.A., Suga, J.M., Chia, S., Saura, C., Garcia-Saenz, J.Á., Gambardella, V., de Miguel, M.J., Gal-Yam, E.N., Rapael, A., Stemmer, S.M., Ma, C., Hanker, A.B., Ye, D., Goldman, J.W., Bose, R., Peterson, L., Bell, J.S.K., Frazier, A., DiPrimeo, D., Wong, A., Arteaga, C.L., Solit, D.B.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
Gestational breast cancer: distinctive molecular and clinico-epidemiological features
de la Haba-Rodríguez, J. R., Mínguez, P., Rojo, F., Martín, M., Alba, E., Servitja, S., Prat, A., Pérez-Fidalgo, J. A., Gavilá, J., Morales, C., Rodriguez-Lescure, A., Herrero, C., Peña-Enriquez, R, Herranz, J., Hernando, C., Hernández-Blanquisett, A., Guil-Luna, S., Martinez, MT, Blanch, S., Caballero, R., Martín, N., Pollán, M., Guerrero-Zotano, A., Bermejo, B.
Published in Journal of mammary gland biology and neoplasia (01.12.2024)
Published in Journal of mammary gland biology and neoplasia (01.12.2024)
Get full text
Journal Article
A retrospective, multicenter study of the efficacy of lapatinib plus trastuzumab in HER2-positive metastatic breast cancer patients previously treated with trastuzumab, lapatinib, or both: the Trastyvere study
Gavilá, J., De La Haba, J., Bermejo, B., Rodríguez-Lescure, Á., Antón, A., Ciruelos, E., Brunet, J., Muñoz-Couselo, E., Santisteban, M., Rodríguez Sánchez, C. A., Santaballa, A., Sánchez Rovira, P., García Sáenz, J. Á., Ruiz-Borrego, M., Guerrero-Zotano, A. L., Huerta, M., Cotes-Sanchís, A., Lao Romera, J., Aguirre, E., Cortés, J., Llombart-Cussac, A.
Published in Clinical & translational oncology (01.03.2020)
Published in Clinical & translational oncology (01.03.2020)
Get full text
Journal Article
A prognostic index for locoregional recurrence after neoadjuvant chemotherapy
Herrero-Vicent, C, Guerrero-Zotano, A, Gavilá-Gregori, J, Hernández-Blanquisett, A, Sandiego-Contreras, S, Samper-Hiraldo, J M, Guillem-Porta, V, Ruiz-Simón, A
Published in Ecancermedicalscience (16.06.2016)
Published in Ecancermedicalscience (16.06.2016)
Get full text
Journal Article
35 High pathologic complete remission rate with liposome-encapsulated doxorubicin + paclitaxel + trastuzumab as primary treatment in HER-2 positive operable breast cancer: clinical experience
Gavila, J, Guerrero-Zotano, A, Climent, M.A, Blanch, S, Guillem, V, Camp, J, Tortajada, M.I, Gozalbo, F, Vidal, P, Ruiz, A
Published in European journal of cancer supplements (2010)
Published in European journal of cancer supplements (2010)
Get full text
Journal Article
Abstract PD7-10: Neoadjuvant trial with letrozole identifies PRR11 in 17q21-23 amplicon as a resistance mechanism to endocrine therapy in ER-positive breast cancer
Lee, K-M, Guerrero-Zotano, A, Formisano, L, Jansen, V, Gonzalez Ericsson, P, Arteaga, C
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Get full text
Journal Article
45P Long-term efficacy of neratinib in HER2-positive early-stage breast cancer: Overall survival and central nervous system outcomes from the phase III ExteNET trial
Chan, A., Moy, B., Mansi, J.L., Gnant, M.I., Barrios, C.H., Separovic, R., Guerrero-Zotano, A., Gore, I., Smith, J., Bryce, R.P., Xu, F., Wong, A., Martin, M., Holmes, F.A.
Published in Annals of oncology (01.05.2021)
Published in Annals of oncology (01.05.2021)
Get full text
Journal Article
Trajectories of alcohol consumption during life and the risk of developing breast cancer
Donat-Vargas, Carolina, Guerrero-Zotano, Ángel, Casas, Ana, Baena-Cañada, José Manuel, Lope, Virginia, Antolín, Silvia, Garcia-Saénz, José Ángel, Bermejo, Begoña, Muñoz, Montserrat, Ramos, Manuel, de Juan, Ana, Jara Sánchez, Carlos, Sánchez-Rovira, Pedro, Antón, Antonio, Brunet, Joan, Gavilá, Joaquín, Salvador, Javier, Arriola Arellano, Esperanza, Bezares, Susana, Fernández de Larrea-Baz, Nerea, Pérez-Gómez, Beatriz, Martín, Miguel, Pollán, Marina
Published in British journal of cancer (12.10.2021)
Published in British journal of cancer (12.10.2021)
Get full text
Journal Article
Type does matter. Use VIRGIN olive oil as your preferred fat to reduce your risk of breast cancer: case-control EpiGEICAM study
Donat-Vargas, Carolina, Guerrero-Zotano, Ángel, Lope, Virginia, Bermejo, Begoña, Casas, Ana, Baena-Cañada, José Manuel, Antolín, Silvia, Sánchez-Rovira, Pedro, Antón, Antonio, Garcia-Saénz, José Ángel, Ramos, Manuel, Muñoz, Montserrat, de Juan, Ana, Jara Sánchez, Carlos, Chacón, José Ignacio, Gil-Gil, Miguel, Andrés Conejero, Raquel, Llombart, Antonio, Bezares, Susana, Fernández de Larrea-Baz, Nerea, Pérez-Gómez, Beatriz, Martín, Miguel, Pollán, Marina
Published in European journal of clinical nutrition (01.09.2022)
Published in European journal of clinical nutrition (01.09.2022)
Get full text
Journal Article
Relapsed hepatocellular carcinoma in transplanted liver. Local involvement and spread through the abdominal wall
Segura Huerta, A, Palomar Abad, L, Molina Saera, J, Guerrero Zotano, A, Pellín Ariño, L
Published in Revista española de enfermedades digestivas (01.06.2004)
Published in Revista española de enfermedades digestivas (01.06.2004)
Get full text
Journal Article
Incidence and predictors of ovarian function recovery (OFR) in exemestane patients with breast cancer (BC) with chemotherapy-induced amenorrhea (CIA) using two estradiol assays
Guerrero-Zotano, A., Gavila, J., Folkerd, E., Ortiz, B., Labrador, T., Martinez, F., Garcia, A., Climent, M. A., Guillem, V., Dowsett, M., Ruiz, A.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Response to neoadjuvant chemotherapy and outcome based on breast cancer subtype
Guerrero-Zotano, A., Gavila, J., Climent, M. A., Juan, M. J., Guillem, V., Ruiz, A.
Published in Journal of clinical oncology (20.05.2009)
Published in Journal of clinical oncology (20.05.2009)
Get full text
Journal Article
Abstract PD5-02: Not presented
Guerrero-Zotano, AL, Stricker, TP, Hutchinson, KE, Stover, DG, Formisano, L, Lee, K-M, Schwarz, LJ, Giltnane, JM, Jansen, VM, Gavila, J, Perez-Fidalgo, A, Lluch, A, Llombart, A, Bayar, MA, Michiels, S, André, F, Arnedos, M, Ruiz, A, Arteaga, CL
Published in Cancer research (Chicago, Ill.) (15.02.2018)
Published in Cancer research (Chicago, Ill.) (15.02.2018)
Get full text
Journal Article
Abstract P1-13-08: Extended adjuvant neratinib/fulvestrant blocks ER/HER2 crosstalk and maintains complete responses of ER+/HER2+ tumors following treatment with chemotherapy and anti-HER2 therapy
Sudhan, DR, Schwarz, LJ, Guerrero-Zotano, AL, Nixon, M, Formisano, L, Croessmann, S, Gonzalez Ericsson, PI, Sanders, ME, Balko, JM, Avogadri-Connors, F, Cutler, RE, Lalani, AS, Bryce, R, Auerbach, A, Arteaga, CL
Published in Cancer research (Chicago, Ill.) (15.02.2018)
Published in Cancer research (Chicago, Ill.) (15.02.2018)
Get full text
Journal Article
Abstract GS6-05: Gain-of-function kinase library screen identifies FGFR1 amplification as a mechanism of resistance to antiestrogens and CDK4/6 inhibitors in ER+ breast cancer
Formisano, L, Lu, Y, Jansen, VM, Bauer, JA, Hanker, A, Gonzalez Ericsson, P, Lee, K-M, Nixon, MJ, Guerrero-Zotano, AL, Schwarz, LJ, Sanders, M, Sudhan, D, Dugger, TC, Cruz, MR, Behdad, A, Cristofanilli, M, Bardia, A, O'Shaughnessy, J, Mayer, IA, Arteaga, CL
Published in Cancer research (Chicago, Ill.) (15.02.2018)
Published in Cancer research (Chicago, Ill.) (15.02.2018)
Get full text
Journal Article
Corroboration of polymorphisms in the aromatase (CYP19A1) gene with response to neoadjuvant therapy with letrozole in postmenopausal women with stages II-II ER/PgR-positive breast cancer
Lopez-Guerrero, J. A., Garcia-Casado, Z., Guerrero-Zotano, A. L., Calatrava, A., Ruiz-Sauri, A., Fernandez-Serra, A., Ruiz, A., Llombart-Bosch, A., Guillem-Porta, V., Llombart-Cussac, A.
Published in Journal of clinical oncology (20.06.2007)
Published in Journal of clinical oncology (20.06.2007)
Get full text
Journal Article
Abstract S5-02: Neratinib after trastuzumab-based adjuvant therapy in early-stage HER2+ breast cancer: 3-year analysis from a phase 3 randomized, placebo-controlled, double-blind trial (ExteNET)
Chan, A, Delaloge, S, Holmes, FA, Moy, B, Iwata, H, Harker, G, Masuda, N, Neskovic Konstantinovic, ZB, Petrakova, K, Guerrero Zotano, AL, Iannotti, N, Rodriguez, GI, Tassone, P, von Minckwitz, G, Ejlertsen, B, Chia, SKL, Mansi, J, Barrios, CH, Buyse, M, Wong, A, Bryce, R, Ye, Y, Martin, M
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Get full text
Journal Article